Traders News Issues Research on High Growth Canna and Pharma Stocks

New York, NY -- April 25, 2018 -- InvestorsHub NewsWire -- OWC Pharmaceutical Research Corp. (OTCBB: OWCP), through its subsidiary, One World Cannabis Ltd., conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions, including multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder, and migraines. One World Cannabis filed eight provisional patent applications and PCTs, all related to its line of activity (pharmaceutical formulations; drug delivery; therapeutic uses of cannabinoids and other cannabis compounds), as well as know-how and trade secrets.

Get our research reports and our low float feature report with no obligation READ MORE
Copy and paste to browser may be required – https://secure.blueoctane.net/forms/E0HDS9E3YN50

Innovation Pharmaceuticals (OTCBB: IPIX), a clinical stage biopharmaceutical company, develops small molecule therapies to treat cancer, antibiotics, and inflammatory disease. April 16, 2018 Innovation Pharmaceuticals reported additional information from the Company’s successfully completed Phase 2 clinical trial of Brilacidin-OM. The Company is developing Brilacidin-OM under FDA Fast Track designation

PotNetwork Holding, Inc. (OTCBB: POTN), through its subsidiary, Diamond CBD, Inc., focuses on research, development, and marketing of hemp extracts that contain a range of cannabinoids and natural hemp derivatives. April 10, 2018 PotNetwork Holdings, Inc. announced record breaking sales performance for March 2018. With over $2.2 million in sales revenue recorded across the month, the company has posted a 152% year over year increase when compared with March 2017. With over $6.3 million in revenues recorded for Q1 of 2018, PotNetwork Holdings, Inc. is well on track to exceed its performance in 2017.

Get our research reports with no obligation and our low float feature report READ MORE
Copy and paste to browser may be required – https://secure.blueoctane.net/forms/E0HDS9E3YN50

Smart Cannabis Corp. (OTCBB: SCNA), is a holding company focused in growing through acquisitions of intellectual property and companies poised to capitalize on advanced agriculture and the use of smart greenhouse systems for organic food production, medicine science, and the explosive cannabis and hemp industries. On April 23, 2018 they announced that it has completed three more customer projects including greenhouses, full installation services, and recurring software subscriptions for its SMARTAPP automation software.

Disclosure

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS LLC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. TNS LLC provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:
editor@tradersnewssource.com
SOURCE: Traders News Source